944718-31-4

Basic information

• Product Name: 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole
• Synonyms: 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole;5-Bromo-1-methylbenzotriazole
• CAS NO: 944718-31-4
• Molecular Formula: C₇H₆BrN₃
• Molecular Weight: 212.04664
• Mol File: 944718-31-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 332.6±15.0 °C(Predicted)
• Appearance: /
• Density: 1.76±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 0.40±0.30(Predicted)
• CAS DataBase Reference: 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole(944718-31-4)
• EPA Substance Registry System: 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole(944718-31-4)

Safety Data

• Hazardous Substances Data: 944718-31-4(Hazardous Substances Data)

Usage

General Description

5-Bromo-1-Methyl-1H-benzo[d][1,2,3]triazole is a chemical compound with the molecular formula C8H6BrN3. It is a benzotriazole derivative, which is commonly used as a corrosion inhibitor in various industrial applications. 5-BroMo-1-Methyl-1H-benzo[d][1,2,3]triazole is a heterocyclic organic compound that contains a bromine atom, a methyl group, and a triazole ring. It is also used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes. Additionally, this compound is known for its antimicrobial and antifungal properties, making it useful in the formulation of personal care products and pharmaceuticals. It is important to handle this chemical with care, as it is toxic if ingested and can cause irritation to the skin and eyes.

Upstream product

• 74-88-4 methyl iodide 
• 364-73-8 4-Bromo-1-fluoro-2-nitrobenzene 
• 53484-26-7 N-methyl-4-bromo-2-nitroaniline 
• 69038-76-2 2-N-methylamino-5-bromoaniline 
• 32046-62-1 5-bromo-1H-benzotriazole 

Downstream Products

• 1396753-41-5 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole 
• 27799-83-3 1-methyl-1H-benzo [d][1,2,3]triazole-5-amine 

Relevant articles and documents

SUBSTITUTED QUINOXALINE DERIVATIVES

The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.

HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS

This invention relates to compounds of the Formula: (I); or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-α or combinations thereof.